F
Fang Zhao
Researcher at Southern University of Science and Technology
Publications - 5
Citations - 2060
Fang Zhao is an academic researcher from Southern University of Science and Technology. The author has contributed to research in topics: Viral load & China. The author has an hindex of 3, co-authored 3 publications receiving 1742 citations.
Papers
More filters
Journal ArticleDOI
Treatment of 5 Critically Ill Patients With COVID-19 With Convalescent Plasma.
Chenguang Shen,Zhaoqin Wang,Fang Zhao,Yang Yang,Jinxiu Li,Jing Yuan,Fuxiang Wang,Delin Li,Delin Li,Minghui Yang,Li Xing,Jinli Wei,Haixia Xiao,Haixia Xiao,Yan Yang,Jiuxin Qu,Ling Qing,Li Chen,Zhixiang Xu,Ling Peng,Yanjie Li,Haixia Zheng,Feng Chen,Kun Huang,Yujing Jiang,Dongjing Liu,Zheng Zhang,Yingxia Liu,Lei Liu +28 more
TL;DR: In this preliminary uncontrolled case series of 5 critically ill patients with COVID-19 and ARDS, administration of convalescent plasma containing neutralizing antibody was followed by improvement in their clinical status, and these observations require evaluation in clinical trials.
Journal ArticleDOI
The Time Sequences of Respiratory and Rectal Viral Shedding in Patients With Coronavirus Disease 2019.
Journal ArticleDOI
Predicting Illness Severity and Short-Term Outcomes of COVID-19: A Retrospective Cohort Study in China
Chuming Chen,Haihui Wang,Zhichao Liang,Ling Peng,Fang Zhao,Liuqing Yang,Mengli Cao,Weibo Wu,Xiao Jiang,Peiyan Zhang,Yinfeng Li,Li Chen,Shiyan Feng,Jianming Li,Lingxiang Meng,Huishan Wu,Fuxiang Wang,Quanying Liu,Yingxia Liu +18 more
TL;DR: Among 249 discharged COVID-19 patients, those who recovered after 20 days had a lower count of platelet, lower level of estimated glomerular filtration rate, and higher level of interleukin-6 and myoglobin than those who recover within 20 days.
Journal ArticleDOI
Marburg virus disease: A deadly rare virus is coming.
Fang Zhao,Yun He,Hongzhou Lu +2 more
TL;DR: The current study has briefly summarized the etiology, epidemiology, and clinical symptoms of the Marburgvirus as well as vaccine development and experimental treatments in order to prevent and control this virus.
Journal ArticleDOI
Different clinical guidelines, common goal: To reduce COVID-19 mortality.
TL;DR: In this article , the authors summarized all appropriate clinical interventions to reduce the public health burden caused by COVID-19 according to guidelines from the World Health Organization and 10 countries, i.e., the United States of America (USA), India, France, Germany, Brazil, South Korea, Japan, Italy, the United Kingdom (UK), and China.